299 related articles for article (PubMed ID: 16784542)
1. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
4. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a phospholipase A2 from the venom of the Saw-scaled viper: Novel bactericidal and membrane damaging activities.
Perumal Samy R; Gopalakrishnakone P; Bow H; Puspharaj PN; Chow VT
Biochimie; 2010 Dec; 92(12):1854-66. PubMed ID: 20723574
[TBL] [Abstract][Full Text] [Related]
7. Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics.
Samy RP; Thwin MM; Stiles BG; Satyanarayana-Jois S; Chinnathambi A; Zayed ME; Alharbi SA; Siveen KS; Sikka S; Kumar AP; Sethi G; Lim LH
Biochimie; 2015 Apr; 111():30-44. PubMed ID: 25583073
[TBL] [Abstract][Full Text] [Related]
8. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
Dutta S; Haq S; Hasan MR; Haq JA
BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
[TBL] [Abstract][Full Text] [Related]
10. Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent.
Samy RP; Stiles BG; Chinnathambi A; Zayed ME; Alharbi SA; Franco OL; Rowan EG; Kumar AP; Lim LH; Sethi G
FEBS Open Bio; 2015; 5():928-41. PubMed ID: 26793432
[TBL] [Abstract][Full Text] [Related]
11. Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei.
Perumal Samy R; Manikandan J; Pachiappan A; Ooi EE; Aw LT; Stiles BG; Franco OL; Kandasamy M; Mathi KM; Rane G; Siveen KS; Arunachalam C; Zayed ME; Alharbi SA; Kumar AP; Sethi G; Lim LH; Chow VT
Curr Mol Med; 2015; 15(10):961-74. PubMed ID: 26592245
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides.
Kanthawong S; Nazmi K; Wongratanacheewin S; Bolscher JG; Wuthiekanun V; Taweechaisupapong S
Int J Antimicrob Agents; 2009 Oct; 34(4):309-14. PubMed ID: 19577435
[TBL] [Abstract][Full Text] [Related]
13. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Clinical Isolates of
Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
[No Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
16. Purification, characterization and bactericidal activities of basic phospholipase A2 from the venom of Agkistrodon halys (Chinese pallas).
Perumal Samy R; Gopalakrishnakone P; Ho B; Chow VT
Biochimie; 2008 Sep; 90(9):1372-88. PubMed ID: 18472013
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
Harris P; Engler C; Norton R
Int J Antimicrob Agents; 2011 Jun; 37(6):547-9. PubMed ID: 21481571
[TBL] [Abstract][Full Text] [Related]
19. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
[TBL] [Abstract][Full Text] [Related]
20. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis.
Häussler S; Rohde M; Steinmetz I
Med Microbiol Immunol; 1999 Nov; 188(2):91-7. PubMed ID: 10753061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
